Dec 23, 2025 04:42AM
Nov 12, 2025 09:46AM
Nov 12, 2025 08:00AM
Nov 3, 2025 07:30AM
Nov 3, 2025 07:30AM
Sep 15, 2025 03:26PM
Sep 15, 2025 03:26PM UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
Sep 15, 2025 08:00AM
Sep 15, 2025 08:00AM
Aug 13, 2025 08:00AM
May 14, 2025 08:00AM
Apr 4, 2025 08:00AM
Apr 4, 2025 08:00AM
Mar 18, 2025 04:22PM Kalaris Therapeutics (KLRS) Closes Merger with AlloVir
Mar 18, 2025 04:21PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All